Tpg Group Holdings Sbs Advisors Has Raised Position in Koninklijke Philips N V (PHG); Vanda Pharmaceuticals (VNDA) Shareholder Cubist Systematic Strategies Has Lowered Its Stake by $345,450

May 16, 2018 - By Marie Mckinney

Koninklijke Philips N.V. (NYSE:PHG) Logo

Cubist Systematic Strategies Llc decreased its stake in Vanda Pharmaceuticals Inc (VNDA) by 90.72% based on its latest 2017Q4 regulatory filing with the SEC. Cubist Systematic Strategies Llc sold 23,030 shares as the company’s stock rose 9.54% while stock markets declined. The institutional investor held 2,357 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $36,000, down from 25,387 at the end of the previous reported quarter. Cubist Systematic Strategies Llc who had been investing in Vanda Pharmaceuticals Inc for a number of months, seems to be less bullish one the $893.70 million market cap company. The stock increased 2.08% or $0.35 during the last trading session, reaching $17.15. About 398,091 shares traded. Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) has risen 15.63% since May 16, 2017 and is uptrending. It has outperformed by 4.08% the S&P500.




Tpg Group Holdings Sbs Advisors Inc increased its stake in Koninklijke Philips N V (PHG) by 32.95% based on its latest 2017Q4 regulatory filing with the SEC. Tpg Group Holdings Sbs Advisors Inc bought 218,846 shares as the company’s stock declined 1.21% with the market. The institutional investor held 882,947 shares of the consumer electronics and appliances company at the end of 2017Q4, valued at $33.38 million, up from 664,101 at the end of the previous reported quarter. Tpg Group Holdings Sbs Advisors Inc who had been investing in Koninklijke Philips N V for a number of months, seems to be bullish on the $39.14B market cap company. The stock increased 1.24% or $0.52 during the last trading session, reaching $42.37. About 565,084 shares traded. Koninklijke Philips N.V. (NYSE:PHG) has risen 17.21% since May 16, 2017 and is uptrending. It has outperformed by 5.66% the S&P500.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.26, from 1.43 in 2017Q3. It turned negative, as 19 investors sold VNDA shares while 34 reduced holdings. 16 funds opened positions while 46 raised stakes. 39.77 million shares or 2.28% more from 38.89 million shares in 2017Q3 were reported. University Of Notre Dame Du Lac has invested 0.64% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Glenmede Tru Co Na reported 574 shares or 0% of all its holdings. Royal Bankshares Of Canada holds 0% or 3,880 shares. Bogle Invest Management Limited Partnership De has invested 0.36% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). The Illinois-based Northern Corp has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Parametric Associate Lc holds 0% or 36,241 shares. Weiss Multi has invested 0.02% of its portfolio in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Pnc Fin Ser Gp Inc holds 0.01% or 400,546 shares in its portfolio. Numeric Invsts Ltd Liability Corporation accumulated 628,000 shares. Jacobs Levy Equity Management stated it has 0.01% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Citigroup accumulated 88,871 shares or 0% of the stock. The Ohio-based Strs Ohio has invested 0% in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Rice Hall James & Associates Limited Liability, California-based fund reported 28,245 shares. Panagora Asset Mgmt owns 268,534 shares for 0.02% of their portfolio. State Street Corporation accumulated 2.14 million shares.

More recent Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) news were published by: Benzinga.com which released: “Benzinga’s Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings” on May 02, 2018. Also Globenewswire.com published the news titled: “Investor Expectations to Drive Momentum within Plains Group Holdings, EnteroMedics, Vanda Pharmaceuticals …” on May 10, 2018. Seekingalpha.com‘s news article titled: “Vanda Pharmaceuticals’ (VNDA) CEO Mihael Polymeropoulos on Q1 2018 Results – Earnings Call Transcript” with publication date: May 03, 2018 was also an interesting one.

Cubist Systematic Strategies Llc, which manages about $1.88B US Long portfolio, upped its stake in Ross Stores Inc (NASDAQ:ROST) by 6,476 shares to 12,146 shares, valued at $975,000 in 2017Q4, according to the filing. It also increased its holding in Energizer Hldgs Inc New by 12,957 shares in the quarter, for a total of 22,193 shares, and has risen its stake in Curtiss Wright Corp (NYSE:CW).

Analysts await Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) to report earnings on August, 1. They expect $-0.05 EPS, down 66.67% or $0.02 from last year’s $-0.03 per share. After $0.06 actual EPS reported by Vanda Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts -183.33% negative EPS growth.

Among 8 analysts covering Vanda Pharmaceuticals (NASDAQ:VNDA), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Vanda Pharmaceuticals had 24 analyst reports since September 2, 2015 according to SRatingsIntel. Jefferies maintained Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Monday, September 4. Jefferies has “Buy” rating and $21.0 target. Brean Capital initiated Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rating on Wednesday, October 21. Brean Capital has “Buy” rating and $20 target. The stock has “Buy” rating by Piper Jaffray on Wednesday, September 2. The firm earned “Buy” rating on Tuesday, June 27 by Piper Jaffray. Oppenheimer maintained the shares of VNDA in report on Monday, March 5 with “Buy” rating. The rating was maintained by Seaport Global with “Buy” on Wednesday, February 28. Oppenheimer maintained the stock with “Buy” rating in Monday, January 8 report. The firm has “Buy” rating by Jefferies given on Thursday, October 6. The firm has “Buy” rating by Oppenheimer given on Sunday, November 12. As per Wednesday, March 9, the company rating was maintained by JMP Securities.

Since January 2, 2018, it had 0 buys, and 8 insider sales for $4.89 million activity. $68,473 worth of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) was sold by Gulino Richard L. on Wednesday, February 28. Kelly James Patrick sold 9,155 shares worth $140,494. 8,568 shares were sold by Birznieks Gunther, worth $130,777.

More news for Koninklijke Philips N.V. (NYSE:PHG) were recently published by: Seekingalpha.com, which released: “Koninklijke Philips’s (PHG) CEO Frans van Houten on Q1 2018 Results – Earnings Call Transcript” on April 23, 2018. Bizjournals.com‘s article titled: “800 health-tech jobs are heading to this downtown building” and published on May 14, 2018 is yet another important article.

Among 14 analysts covering Koninklijke Philips N.V. (NYSE:PHG), 7 have Buy rating, 0 Sell and 7 Hold. Therefore 50% are positive. Koninklijke Philips N.V. had 15 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, February 12 by Berenberg. On Monday, October 16 the stock rating was downgraded by BNP Paribas to “Neutral”. The stock of Koninklijke Philips N.V. (NYSE:PHG) earned “Outperform” rating by Credit Suisse on Tuesday, September 8. As per Thursday, August 27, the company rating was upgraded by Nomura. As per Tuesday, June 20, the company rating was downgraded by Deutsche Bank. The stock of Koninklijke Philips N.V. (NYSE:PHG) earned “Buy” rating by UBS on Wednesday, August 10. The firm earned “Buy” rating on Wednesday, November 23 by Citigroup. ING Group initiated Koninklijke Philips N.V. (NYSE:PHG) on Friday, November 27 with “Hold” rating. The rating was upgraded by BNP Paribas to “Outperform” on Wednesday, May 11. The firm earned “Outperform” rating on Wednesday, September 2 by RBC Capital Markets.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts